Nordea Investment Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.2M Buy
81,684
+24,255
+42% +$2.06M 0.01% 530
2026
Q1
$4.72M Sell
57,429
-2,823
-5% -$232K ﹤0.01% 601
2025
Q4
$5.51M Sell
60,252
-8,538
-12% -$817K ﹤0.01% 568
2025
Q3
$6.52M Buy
68,790
+9,058
+15% +$852K 0.01% 535
2025
Q2
$6.32M Buy
59,732
+164
+0.3% +$15.5K 0.01% 517
2025
Q1
$5.15M Sell
59,568
-244
-0.4% -$25K 0.01% 530
2024
Q4
$5.75M Buy
59,812
+2,757
+5% +$257K 0.01% 509
2024
Q3
$4.63M Buy
57,055
+26,825
+89% +$2.07M 0.01% 544
2024
Q2
$2.58M Sell
30,230
-4,509
-13% -$364K ﹤0.01% 652
2024
Q1
$2.85M Sell
34,739
-483
-1% -$37.7K ﹤0.01% 653
2023
Q4
$2.34M Sell
35,222
-356
-1% -$24.7K ﹤0.01% 681
2023
Q3
$2.62M Buy
35,578
+22,705
+176% +$1.53M ﹤0.01% 645
2023
Q2
$810K Sell
12,873
-3,704
-22% -$215K ﹤0.01% 844
2023
Q1
$974K Buy
16,577
+168
+1% +$10.2K ﹤0.01% 793
2022
Q4
$999K Buy
+16,409
New +$1.1M ﹤0.01% 776

Other funds holding HQY

Nordea Investment Management's HQY Position: Q2 2026 in Review

Nordea Investment Management increased its HealthEquity (HQY) stake by 42% in Q2 2026, buying an estimated $2.06M and bringing the position to 81,684 shares worth $7.2M. The position accounts for 0.01% of the portfolio, ranked #530.

Nordea Investment Management first reported a position in HQY in Q4 2022 and has held it in 15 quarters since. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Nordea Investment Management held 81,684 shares of HealthEquity worth $7.2M as of Q2 2026.
  • Nordea Investment Management bought 24,255 HealthEquity shares in Q2 2026, an estimated $2.06M.
  • HealthEquity made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #530 holding.
  • Nordea Investment Management first reported a position in HealthEquity in Q4 2022 and has held it in 15 quarters since.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.